439 results on '"A., Kawakami"'
Search Results
2. MP09-03 COMPARATIVE STUDY OF SIGNIFICANT CANCER DETECTION IN MAGNETIC RESONANCE IMAGING-TRANSRECTAL ULTRASOUND FUSION IMAGE-GUIDED PROSTATE TARGET BIOPSY AND TRANSPERINEAL TEMPLATE-GUIDED SYSTEMATIC BIOPSY: A 15-CENTER PROSPECTIVE STUDY IN JAPAN
3. MP14-17 SMARCD1 REGULATED BY MICRORNA-99A-5P CONTRIBUTES TO GEMCITABINE RESISTANCE IN BLADDER CANCER VIA SUPPRESSION OF CELLULAR SENESCENCE
4. LBA01-18 COMPARISON OF MIRABEGRON AND VIBEGRON FOR CLINICAL EFFICACY AND SAFETY IN FEMALE PATIENTS WITH OVERACTIVE BLADDER: A MULTICENTER, PROSPECTIVE RANDOMIZED CROSSOVER TRIAL
5. MP09-08 PREDICTIVE VALUE OF LACDINAC-GLYCOSYLATED PROSTATE SPECIFIC ANTIGEN AT 3 MONTHS AFTER FOCAL THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND FOR DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER DURING FOLLOW-UP: A MULTI-INSTITUTIONAL STUDY
6. LBA01-18 COMPARISON OF MIRABEGRON AND VIBEGRON FOR CLINICAL EFFICACY AND SAFETY IN FEMALE PATIENTS WITH OVERACTIVE BLADDER: A MULTICENTER, PROSPECTIVE RANDOMIZED CROSSOVER TRIAL
7. MP09-03 COMPARATIVE STUDY OF SIGNIFICANT CANCER DETECTION IN MAGNETIC RESONANCE IMAGING-TRANSRECTAL ULTRASOUND FUSION IMAGE-GUIDED PROSTATE TARGET BIOPSY AND TRANSPERINEAL TEMPLATE-GUIDED SYSTEMATIC BIOPSY: A 15-CENTER PROSPECTIVE STUDY IN JAPAN
8. MP09-08 PREDICTIVE VALUE OF LACDINAC-GLYCOSYLATED PROSTATE SPECIFIC ANTIGEN AT 3 MONTHS AFTER FOCAL THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND FOR DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER DURING FOLLOW-UP: A MULTI-INSTITUTIONAL STUDY
9. MP14-17 SMARCD1 REGULATED BY MICRORNA-99A-5P CONTRIBUTES TO GEMCITABINE RESISTANCE IN BLADDER CANCER VIA SUPPRESSION OF CELLULAR SENESCENCE
10. Reply by Authors
11. Usefulness of LacdiNAc-glycosylated Prostate-specific Antigen Density for Predicting Pathological Findings of Magnetic Resonance Imaging-transrectal Ultrasound Fusion Image-guided Prostate Biopsy for the Patients With Highest Prostate Imaging Reporting and Data System Category ≥3
12. PD01-04 GLUTAMINE BLOCKADE INDUCES CELLULAR SENESCENCE IN RENAL CELL CARCINOMA BY TARGETING SLC1A5
13. PD40-04 HOW DOES MAGNETIC FIELD STRENGTH IN MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING AFFECT SIGNIFICANT PROSTATE CANCER DETECTION? : A MULTICENTER PROPENSITY SCORE–MATCHED ANALYSIS
14. PD57-11 IMPACT OF CONTACT SURFACE AREA AND PI-RADS CATEGORY ON THE CAPSULAR INVASION OF LOCALIZED CANCER WITH SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS ≤20 NG/ML AND TUMOR-CAPSULE CONTACT
15. PD40-06 USEFULNESS OF PROSTATE SPECIFIC ANTIGEN–GLYCOSYLATION ISOMER FOR SIGNIFICANT CANCER DETECTION AND PATHOLOGICAL FINDINGS OF INDEX PROSTATE CANCERS ON MAGNETIC RESONANCE IMAGING–TRANSRECTAL ULTRASOUND FUSION IMAGE-GUIDED BIOPSY: A PROSPECTIVE MULTICENTER STUDY
16. PD40-04 HOW DOES MAGNETIC FIELD STRENGTH IN MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING AFFECT SIGNIFICANT PROSTATE CANCER DETECTION? : A MULTICENTER PROPENSITY SCORE–MATCHED ANALYSIS
17. PD01-04 GLUTAMINE BLOCKADE INDUCES CELLULAR SENESCENCE IN RENAL CELL CARCINOMA BY TARGETING SLC1A5
18. PD40-06 USEFULNESS OF PROSTATE SPECIFIC ANTIGEN–GLYCOSYLATION ISOMER FOR SIGNIFICANT CANCER DETECTION AND PATHOLOGICAL FINDINGS OF INDEX PROSTATE CANCERS ON MAGNETIC RESONANCE IMAGING–TRANSRECTAL ULTRASOUND FUSION IMAGE-GUIDED BIOPSY: A PROSPECTIVE MULTICENTER STUDY
19. PD57-11 IMPACT OF CONTACT SURFACE AREA AND PI-RADS CATEGORY ON THE CAPSULAR INVASION OF LOCALIZED CANCER WITH SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS ≤20 NG/ML AND TUMOR-CAPSULE CONTACT
20. MP64-10 HOW LONG SHOULD UROLOGISTS OBSERVE PATIENTS WITH PROSTATE CANCER AFTER RADICAL PROSTATECTOMY?: WEIBULL ANALYSIS
21. MP39-13 FUNCTION OF EXOSOMAL ANTITUMOR MICRORNA-1 IN RENAL CELL CARCINOMA
22. MP46-13 IMPACT OF INTRA-PROCEDURAL PROSTATE COMPRESSION AND ANDROGEN DEPRIVATION THERAPY IN WHOLE-GLAND THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND ON LOCALIZED PROSTATE CANCER: A RETROSPECTIVE CONSECUTIVE CASE-SERIES ANALYSIS FOR 12-YEAR FOLLOW-UP
23. MP36-08 PRE-PROCEDURAL LOW IIEF-5 AND TREATMENT OF PZ WITH ADJACENT NVB AND THE EJACULATORY DUCT WERE ASSOCIATED WITH SEXUAL DYSFUNCTION AFTER FOCAL THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND: A MULTI-INSTITUTIONAL PROSPECTIVE STUDY
24. MP22-14 SIGNIFICANT IMPACT OF PROSTATE-SPECIFIC ANTIGEN-GLYCOSYLATION ISOMER ON THE PATHOLOGICAL CHARACTERISTICS OF LOCALIZED INDEX PROSTATE CANCERS IN MAGNETIC RESONANCE IMAGING-TRANSRECTAL ULTRASOUND FUSION IMAGE-GUIDED BIOPSY: A MULTI-INSTITUTIONAL PROSPECTIVE STUDY
25. Usefulness of LacdiNAc-glycosylated Prostate-specific Antigen Density for Predicting Pathological Findings of Magnetic Resonance Imaging-transrectal Ultrasound Fusion Image-guided Prostate Biopsy for the Patients with Highest Prostate Imaging...
26. MP39-13 FUNCTION OF EXOSOMAL ANTITUMOR MICRORNA-1 IN RENAL CELL CARCINOMA
27. MP46-13 IMPACT OF INTRA-PROCEDURAL PROSTATE COMPRESSION AND ANDROGEN DEPRIVATION THERAPY IN WHOLE-GLAND THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND ON LOCALIZED PROSTATE CANCER: A RETROSPECTIVE CONSECUTIVE CASE-SERIES ANALYSIS FOR 12-YEAR FOLLOW-UP
28. MP36-08 PRE-PROCEDURAL LOW IIEF-5 AND TREATMENT OF PZ WITH ADJACENT NVB AND THE EJACULATORY DUCT WERE ASSOCIATED WITH SEXUAL DYSFUNCTION AFTER FOCAL THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND: A MULTI-INSTITUTIONAL PROSPECTIVE STUDY
29. MP64-10 HOW LONG SHOULD UROLOGISTS OBSERVE PATIENTS WITH PROSTATE CANCER AFTER RADICAL PROSTATECTOMY?: WEIBULL ANALYSIS
30. MP42-20 CLINICAL PREDICTORS FOR DETECTION OF SIGNIFICANT CANCER IN FOLLOW-UP BIOPSY AFTER FOCAL THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND FOR LOCALIZED PROSTATE CANCER: A MULTI-INSTITUTIONAL STUDY
31. MP42-12 PREDICTIVE VALUE OF LIQUID BIOPSY OF SERUM PSA-GLYCOSYLATION ISOMER FOR PATHOLOGICAL CHARACTERISTICS OF LOCALIZED INDEX PROSTATE CANCERS: A MULTI-INSTITUTIONAL STUDY
32. MP42-07 USEFULNESS OF COMPUTER-AIDED DIAGNOSIS SYSTEM IN EVALUATING SEVERITY OF BENIGN PROSTATIC HYPERPLASIA, USING A SUPER-ELLIPSE MODEL TO CHARACTERIZE CHANGES IN PROSTATE CONTOURS
33. MP42-20 CLINICAL PREDICTORS FOR DETECTION OF SIGNIFICANT CANCER IN FOLLOW-UP BIOPSY AFTER FOCAL THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND FOR LOCALIZED PROSTATE CANCER: A MULTI-INSTITUTIONAL STUDY
34. MP42-12 PREDICTIVE VALUE OF LIQUID BIOPSY OF SERUM PSA-GLYCOSYLATION ISOMER FOR PATHOLOGICAL CHARACTERISTICS OF LOCALIZED INDEX PROSTATE CANCERS: A MULTI-INSTITUTIONAL STUDY
35. MP42-07 USEFULNESS OF COMPUTER-AIDED DIAGNOSIS SYSTEM IN EVALUATING SEVERITY OF BENIGN PROSTATIC HYPERPLASIA, USING A SUPER-ELLIPSE MODEL TO CHARACTERIZE CHANGES IN PROSTATE CONTOURS
36. Study of the Kidney Tumor-Parenchymal Interface after Neoadjuvant Treatment with Axitinib for Locally Advanced Clear Cell Renal Cell Carcinoma: Matched Analysis from a Phase II Trial
37. MP42-07 ONCOLOGICAL OUTCOMES OF PATIENTS WITH SPORADIC, NON-METASTATIC RENAL CELL CARCINOMA WITH RENAL VEIN OR INFERIOR VENA CAVA TUMOR THROMBUS
38. PD46-01 IMPACT OF TIME-TO-SURGERY AND SURGICAL DELAY ON ONCOLOGIC OUTCOMES FOR RENAL CELL CARCINOMA
39. PD12-07 PREDICTORS OF PATHOLOGICALLY NODE POSITIVE DISEASE IN PATIENTS UNDERGOING RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) FOR RENAL CELL CARCINOMA (RCC): RESULTS FROM THE CANADIAN KIDNEY CANCER COLLABORATION
40. MP48-15 DOES PARTIAL NEPHRECTOMY FOR BIOPSY PROVEN FUHRMAN GRADE 3/4 RENAL CELL CARCINOMA CONFER WORSE OUTCOMES COMPARED TO RADICAL NEPHRECTOMY? RESULTS FROM A CANADIAN MUTLICENTER COHORT
41. MP72-20 SOMATIC MUTATIONS IN MITOCHONDRIAL DNA PREDICT POSTOPERATIVE RECURRENCE IN RENAL CELL CARCINOMA
42. MP42-07 ONCOLOGICAL OUTCOMES OF PATIENTS WITH SPORADIC, NON-METASTATIC RENAL CELL CARCINOMA WITH RENAL VEIN OR INFERIOR VENA CAVA TUMOR THROMBUS
43. PD46-01 IMPACT OF TIME-TO-SURGERY AND SURGICAL DELAY ON ONCOLOGIC OUTCOMES FOR RENAL CELL CARCINOMA
44. MP02-20 DEFINITIVE MANAGEMENT OF CARCINOGENIC SURGICAL SMOKE DURING TRANSURETHRAL RESECTION OF THE PROSTATE USING A CLOSED IRRIGATION SYSTEM
45. MP04-19 PROGNOSTIC IMPACT OF SERUM CYFRA 21-1 AMONG CLASSIC TUMOR MARKERS IN PATIENTS WITH NON-METASTATIC BUT POTENTIALLY LETHAL BLADDER CANCER
46. PD11-09 THE ACCURACY OF REAL-TIME MRI-TRUS FUSION IMAGE-GUIDED TRANSPERINEAL TARGET BIOPSY WITH NEEDLE TRACKING OF MECHANICAL POSITION-ENCODED STEPPER IN THE DETECTION OF THE SIGNIFICANT PROSTATE CANCER FOR THE BIOPSY NAÏVE MEN
47. Restoring Erectile Function by Antioxidant Therapy in Diabetic Rats
48. MP48-15 DOES PARTIAL NEPHRECTOMY FOR BIOPSY PROVEN FUHRMAN GRADE 3/4 RENAL CELL CARCINOMA CONFER WORSE OUTCOMES COMPARED TO RADICAL NEPHRECTOMY? RESULTS FROM A CANADIAN MUTLICENTER COHORT
49. PD12-07 PREDICTORS OF PATHOLOGICALLY NODE POSITIVE DISEASE IN PATIENTS UNDERGOING RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) FOR RENAL CELL CARCINOMA (RCC): RESULTS FROM THE CANADIAN KIDNEY CANCER COLLABORATION
50. MP72-20 SOMATIC MUTATIONS IN MITOCHONDRIAL DNA PREDICT POSTOPERATIVE RECURRENCE IN RENAL CELL CARCINOMA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.